Surgical vs Medical Management for Intracerebral Hemorrhage
(REACH Trial)
Trial Summary
What is the purpose of this trial?
The main purpose of this study is to compare patients with a deep bleed in the brain undergoing surgery to patients receiving routine medical care. The standard treatment involves admission to the Intensive Care Unit (ICU) with close monitoring and blood pressure control. It also includes other medical (non-surgical) treatments to prevent more bleeding or another stroke. Sometimes, doctors will recommend surgery to remove the blood if medical treatment alone is not successful. There is evidence that doing minimally invasive surgery early-using a small opening in the skull to remove blood-may help some patients. Researchers aim to understand whether this surgery is better than current medical treatment, which may include surgeries to relieve pressure on the brain in some cases. This study, called REACH, is comparing usual medical care to early minimally invasive surgery so doctors can know which is better for patients.
Eligibility Criteria
This trial is for individuals who have experienced a deep hemorrhagic stroke, which is bleeding within the brain. Participants should not have had previous treatments that would affect the study's outcomes. The trial excludes those with conditions that may interfere with surgery or medical management, and those who are unlikely to follow the study protocol.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Surgical management (Procedure)